Last reviewed · How we verify
HGP0904 and HGP1201 co-administraion
HGP0904 and HGP1201 co-administraion is a Small molecule drug developed by Hanmi Pharmaceutical Company Limited. It is currently in Phase 1 development.
At a glance
| Generic name | HGP0904 and HGP1201 co-administraion |
|---|---|
| Sponsor | Hanmi Pharmaceutical Company Limited |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HGP0904 and HGP1201 co-administraion CI brief — competitive landscape report
- HGP0904 and HGP1201 co-administraion updates RSS · CI watch RSS
- Hanmi Pharmaceutical Company Limited portfolio CI
Frequently asked questions about HGP0904 and HGP1201 co-administraion
What is HGP0904 and HGP1201 co-administraion?
HGP0904 and HGP1201 co-administraion is a Small molecule drug developed by Hanmi Pharmaceutical Company Limited.
Who makes HGP0904 and HGP1201 co-administraion?
HGP0904 and HGP1201 co-administraion is developed by Hanmi Pharmaceutical Company Limited (see full Hanmi Pharmaceutical Company Limited pipeline at /company/hanmi-pharmaceutical-company-limited).
What development phase is HGP0904 and HGP1201 co-administraion in?
HGP0904 and HGP1201 co-administraion is in Phase 1.